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Synthesis of thiazole analogues of the immunosuppressive agent 
(1R,2S,3R)-2-acetyl-4(5)-(1,2,3,4-tetrahydroxybutyl)imidazole 
Abstract 
The synthesis of four of the diastereoisomers of 2-acetyl-5-(1,2,3,4-tetrahydroxybutyl)thiazole and two of 
the diastereoisomers of 2-acetyl-5-(1,2,3,4,5-pentahydroxypentyl)thiazole and 
2-acetyl-4-(1,2,3,4,5-pentahydroxypentyl)thiazole are reported. These syntheses involve the condensation 
of 5- or 4-metallated 2-(1,1-dimethoxyethyl)thiazoles with 2,3-O-isopropylidene-D-erythrono-1,4-lactone or 
5-O-(tert-butyldimethylsilyl)-2,3-O-isopropylidene-D-ribonolactone followed by reductive ring-opening of 
the resulting lactols. The stereochemistries and structures of some key compounds have been 
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Synthesis of 5-(1,2,3,4,5,6-hexahydroxhexyl)thiazole analogues of the 
immunosuppressive agent (1R, 2S, 3R)-2-acetyl-4(5)-(1,2,3,4-
tetrahydroxybutyl)imidazole 
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Summary: The synthesis of four of the diastereoisomers of 2-acetyl-5-(1,2,3,4,5,6-
hexaahydroxyhexyl)thiazole are reported.  These syntheses involve the condensation 
of 5-lithiated-2-(1,1-dimethoxyethyl)-thiazole with a N-acyl morpholine derivative of 
g-gluconolactone or 2,3:5,6-Di-O-isopropylidene-mannolactone followed by hydride 
reduction of the resulting ketone and lactol, respectively.  The stereochemistries and 




As part of an ongoing medicinal chemistry project1-7 we required the synthesis of some 
5-hexahydroxyhexylthiazole analogues, 4, of the known immunosuppressive agent, 
(1R, 2S, 3R)-2-acetyl-4(5)-(1,2,3,4-tetrahydroxybutyl)imidazole (THI) 1.8-10 THI is a 
2 
minor component of the common food additive Caramel Colour III.  THI has been 
found to cause lymphopenia (depression of blood lymphocyte counts), without any 
apparent side-effects, in mice and rats that have been given THI in their drinking 
water.8,9  Thus THI and its analogues have potential applications as an 
immunosuppressive agent in organ transplant biology or for preventing the onset of 
diabetes.10  Our earlier studies showed that compound 2, the 5-thiazole analogue of 
THI, had essentially the same activity versus concentration profile as THI in causing 
lymphopenia in mice, while the pentahydroxylpentyl derivative 3 showed a slightly 

































Results and Discussion 
Our earlier strategy for the synthesis of 5-thiazole analogues of THI involves the 
condensation of 5-lithio-2-(1,1-dimethoxyethyl)-thiazole (11) with protected D-
erythrono-1,4-lactone or D-ribonolactone followed by reductive ring-opening of the 
resulting lactols to give protected versions of the requisite analogues.7  Attempts to 
condense the known dioxolanone?, 1,2:3,4:5,6-tri-O-isopropylidene--gluconolactone 
611 with 5-lithio-2-(1,1-dimethoxyethyl)-thiazole7 (THF, -78oC to RT) gave no 
isolatable condensation products and only 2-(1,1-dimethoxyethyl)-thiazole could be 
recovered.  We suspected that deprotonation of 6  to the lactone carbonyl group was 
3 
occurring followed by -elimination of acetone to account for the lack of recovery of 
6.  To this end dioxolanone 6 was treated with choloromethylaluminium 
methoxymethylamine in benzene to yield the Wienreb-type amide derivative 7 in 75% 
yield which was converted to the TBS ether 8 under standard conditions.  Treatment 
of 6 with an excess of morpholine (3.75 molar equiv) by heating in a sealed tube at 
100oC for 24 h gave the N-morpholine amide derivative 9 in 95% yield. The structure 
of the TBS derivative 10 of 9 was unequivocally demonstrated from a single-crystal 
X-ray analysis (Figure 1). Treatment of the N-methoxy,N-methylamide 8 with the 5-
lithiothiazole 11 initially at –78 oC and then at RT for 2 h, followed by column 
chromatography, gave the ketone 12 in only 11% yield. The structure of this 
compound was secured by a single-crystal X-ray analysis (Figure 2).  The reaction of 
11 with the N-morpholine amide 10, however was more successful and gave the 
ketone 12 in 37% purified yield or 67% based on recovered amide 10. 
Scheme 1 
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7; X = N(Me)OMe, R = H
8; X = N(Me)OMe, R = TBS
9; X = N(CH2CH2)2O, R = H
10; X = N(CH2CH2)2O, R = TBS











15; R = H
17, R = Ac
e
16; R = H
18, R = Acff  
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Reduction of 10 with sodium borohydride in methanol at 0 oC afforded an 87 :13 
mixture of the 1,2-syn- and 1,2-anti-products 13 and 14respectively, that could not be 
readily separated by column chromatography.  Fortunately pure syn-13 could be 
obtained by recrystallization of a mixture of 13 and 14 from ethyl acetate / petroleum 
ether and its structure determined by single-crystal X-ray crystallographic analysis 
(Figure 3).  The stereochemistry of the major alcohol 13 is that predicted by the 
Felkin-Anh transition model.10-13 Similar diastereoselectivities were obtained when 12 
was treated with L- or K-selectride (THF) at -78 oC.  Treatment of a diethyl ether 
solution of 10 at -78 oC with precooled (-78 oC) DIBAL-H in diethyl ether was highly 
diastereoselective (dr >98 : <2) and gave essentially pure anti-product 14 in 90% 
yield.  While an anti-product would be expected for reduction of an -ether substituted 
ketone under chelation control the OTBS group is normally too hindered to participate 
in such a mechanism.ref   Acid hydrolysis of the individual diastereoisomers 13 and 14 
gave the hexaols 15 and 16, respectively, that were converted to their corresponding 
hexa-acetates for further characterization. 
Scheme 2 outlines the synthesis of the Reduction of the keto group of the 4-O-silylated 
cis-1,3-dioxolane 16  with a number of reducing agents (NaBH4, DIBAL, Red-AL, K-
selectride and L-selectride) gave mixtures of the diastereoisomeric alcohols 17 and 18.  
The optimum diastereoselectivity was obtained (17:18 = 84:16) when L-selectride was 
employed at –78 oC.  The stereochemistry assigned to 17 was unequivocally 
determined by an X-ray study (Fig. 5) and is that expected from the Felkin-Ahn 
transition state model D.  Acid hydrolysis of the individual diastereoisomers 17 and 18 




























































23; R = H
25, R = Ac
e
24; R = H




Synthesis of 2-acetyl-4-(1,2,3,4,5-pentahydroxypentyl)- and 2-acetyl-5-(1,2,3,4,5-
pentahydroxypentyl)-thiazoles 
The 5-lithio thiazole derivative of 5 was treated with 5-O-(tert-butyldimethylsilyl)-2,3-
O-isopropylidene-D-ribonolactone 2115 at –78 oC for 1.5h to give the lactol 22, as a 
single isomer in 64% yield (Scheme 4).  In contrast to the corresponding reaction of 
lithiated 5 with lactone 6, no ring-opening ketone products were observed.  X-ray 
7 
analysis of 22 showed it had the same relative stereochemistry as 7b with respect to 
the thiazole and 1,3-dioxolane rings (Fig. 6).   Reduction of 22 with sodium 
borohydride in methanol at –10 oC afforded a mixture of the diols 23 and 24. These 
could be isolated in diastereomerically pure form in 48% and 46% yields, respectively, 
by column chromatography. Attempts to reductively ring-open the lactol 22 with other 
reducing agents (e.g. DIBAL and L-selectride) were unsuccessful and only starting 
lactol 22 was recovered. The poor diastereoselectivity in the reduction of 22 is in stark 
contrast to that found for the lactol 7 and is unexpected based on the transition state 
structures A and B.  The corresponding transition state structures E and F for the 
reduction of ring-opened 22 do not appear to be made unfavourable by the extra 
TBSOCH2 group that should occupy a pseudo-equatorial position. Acid hydrolysis of 
the individual diastereoisomers 23 and 24 gave the pentols 25 and 26, respectively, in 
good yields that were converted to their corresponding penta-acetates 27 and 28 
respectively, under standard conditions.4  The stereochemistry of 24 and 27 was 
confirmed by single crystal X-ray analysis (Fig. 7 and 8 ).  
 4-Bromo-2-(1,1-dimethoxyethyl)thiazole6 underwent trans-metallation at  –78 oC and 
was then treated with the lactone 21 at –78 oC for 1.5h (Scheme 5).  Purification of the 
reaction mixture by column chromatography gave the desired lactol 29 (d. r. = 69:31) 
in 44% yield and surprisingly the isomeric 5-thiazole adduct 22 in 15% yield (Scheme 
5). The latter compound must have arisen through formation of the more stable 5-
lithiated thiazole derivative.  Reduction of 29 with sodium borohydride in methanol at 
–10 oC afforded a 60:40 mixture of the diols 30 and 31, respectively. Separation of this 
mixture by column chromatography gave diastereomerically pure 31 and 32 in 30% 
and 21% yields, respectively.  The stereochemistry of 30 was secured by single crystal 
X-ray analysis (Fig. 9). Compounds 30 and 31 were converted to their pentols 32 and 
8 
33 respectively by acid hydrolysis.  Small samples of these pentols were converted to 
their respective penta-acetates, 34 and 35.    The 1H NMR analysis of the tetraacetate 
of THI (1) and its C1 epimer4 and of the diastereomeric pairs 27 and 28 and 34 and 35 
showed that H1, in compounds with the (1R)-stereochemistry (tetraacetate of 1, 27 and 
34), comes further downfield of H1 in their respective isomers having the (1S)-
stereochemistry.  Furthermore, J1,2 is generally smaller in the 1R diastereoisomer. 
 
In conclusion, we have developed a short, efficient and diastereoselective synthesis of 
the (1S, 2S, 3R)- and (1R, 2R 3R)-5-thiazole analogues of the bioactive molecule THI 
from a common precursor, the lactol 3.  This methodology is complementary to the 
Sharpless asymmetric dihydroxylation method for the diastereoselective synthesis of 
the syn-1,2-diol moiety of THI and its analogues that have opposite stereochemistries 
at C-1 and C-2.4,6  Extension of this methodology to prepare the pentahydroxylpentyl 
4-thiazole and 5-thiazole analogues was also efficient but the diastereoselectivity of 
the reductive ring-opening steps were poorly diastereoselective.  Furthermore, this 
approach should be applicable to the diastereoselective synthesis of other 
polyhydroxylated bioactive molecules.  Preliminary experiments on these analogues 
suggested that compound 11, the 5-thiazole analogue of THI, had essentially the same 
activity versus concentration profile as THI in causing lymphopenia in mice, while the 
pental 25 showed a slightly higher activity at the same concentration.   
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